Atara Biotherapeutics: Q2 Earnings Insights

Atara Biotherapeutics: Q2 Earnings Insights


Atara Biotherapeutics ATRA reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.


Atara Biotherapeutics reported an EPS of $-0.31.

Revenue was up $47.71 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 1.47% increase in the share price the next day.

Here's a look at Atara Biotherapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.98 -0.69 -0.94 -0.89
EPS Actual -0.87 -0.96 -0.90 -0.91
Revenue Estimate 4.91M 35.14M 3.92M 3.84M
Revenue Actual 7.31M 7.55M 5.37M 3.87M

To track all earnings releases for Atara Biotherapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings